Send us a link
28 September marks the first celebration of the International Day for Universal Access to Information since its proclamation by the 74th session of the United Nations General Assembly, is of crucial importance.
Researchers warn that vaccines could stumble on safety trials, be fast-tracked because of politics or fail to meet the public's expectations.
Bully and ignore the experts, and send in the quacks.
China blocked the Wikimedia Foundation’s application for observer status at the World Intellectual Property Organization. As a result, the Foundation’s application for observer status has been suspended and will be reconsidered at a future WIPO meeting.
Therapies and vaccines will come, but not for many months. Until then, politicians will have to work on the basics
One of the UK’s leading public health experts has warned that universities should be two-thirds empty in order to prevent massive spikes in coronavirus infections across campuses.
A recent study looked at the number of journals that had "vanished" from the internet. The study is a timely reminder of how vulnerable publishing outputs are. There is an urgent need for a group of organisations to come together to find a solution and minimise this risk.
Abstract. The research policy (RP) arena has been transforming in recent years, turning into a policy mix encompassing the diversity of policy instruments embe
COKI Project Co-lead Professor Cameron Neylon outlines why he is supporting a campaign calling for all abstracts to be made open access.
Appointing early-career researchers to positions of influence within scientific societies would be mutually beneficial for both.
COVID-19 has led to rapid and open sharing of research outputs. But will this new, radically open research communications paradigm result in permanent change?
Some of the leading candidates might work better for the richest people in the world, simply on account of how they're made.
New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journal
Elon Musk made big promises at Tesla's highly anticipated event. But a prototype never appeared, and it was unclear what the company had actually achieved.
Help us increase the visibility of women in STEM and inspire the next generation of women scientists. Join us in writing Wikipedia biographies of women in STEM in October and November.
Immunization has always been a proxy for wider fears about social control, a history reminds us.
Recent advances are bringing cancer vaccines much closer to reality, giving patients another weapon in their arsenal of cancer treatments, according to Dr Madiha Derouazi, CEO of Amal Therapeutics and one of three winners of the 2020 EU Prize for Women Innovators.
The Open Data Day 2021 will take place on 6th March. It is the annual global celebration of open data facilitated by the Open Knowledge Foundation.
In the world of scientific research today, there’s a revolution going on – over the last decade or so, scientists across many disciplines have been seeking to improve the workings of science and its methods. To do this, scientists are largely following one of two paths: the movement for reproducibility and the movement for open science. Both movements aim to create centralized archives for data, computer code and other resources, but from there, the paths diverge.
Online Conference on Open Access Scholarly Publishing: Final program available.
Bringing stakeholders together to shape future research and innovation policy. See the programme, check out the speakers and join online 22-24 September.
The government and vice-chancellors have a duty of care, yet in too many colleges, Covid security is mere hygiene theatre.
Months after infection with SARS-CoV-2, some people are still battling crushing fatigue, lung damage and other symptoms of 'long COVID'.
The aim of the study is not to compare and assess the success of countries’ key Covid policy responses, but rather to compare the various ways in which evidence has been marshalled and applied.
The editors of the Lancet Group examined The Lancet's peer-review processes to identify ways of further reducing risks of research and publication misconduct.
